Sorrento Therapeutics, Inc
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Sorrento Therapeutics, Inc common, CUSIP 83587F020.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Sorrento Therapeutics, Inc common, CUSIP 83587F020.